The Extracellular Matrix in Ischemic and Nonischemic Heart Failure
- 20 June 2019
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation Research
- Vol. 125 (1), 117-146
- https://doi.org/10.1161/CIRCRESAHA.119.311148
Abstract
The ECM (extracellular matrix) network plays a crucial role in cardiac homeostasis, not only by providing structural support, but also by facilitating force transmission, and by transducing key signals to cardiomyocytes, vascular cells, and interstitial cells. Changes in the profile and biochemistry of the ECM may be critically implicated in the pathogenesis of both heart failure with reduced ejection fraction and heart failure with preserved ejection fraction. The patterns of molecular and biochemical ECM alterations in failing hearts are dependent on the type of underlying injury. Pressure overload triggers early activation of a matrix-synthetic program in cardiac fibroblasts, inducing myofibroblast conversion, and stimulating synthesis of both structural and matricellular ECM proteins. Expansion of the cardiac ECM may increase myocardial stiffness promoting diastolic dysfunction. Cardiomyocytes, vascular cells and immune cells, activated through mechanosensitive pathways or neurohumoral mediators may play a critical role in fibroblast activation through secretion of cytokines and growth factors. Sustained pressure overload leads to dilative remodeling and systolic dysfunction that may be mediated by changes in the interstitial protease/antiprotease balance. On the other hand, ischemic injury causes dynamic changes in the cardiac ECM that contribute to regulation of inflammation and repair and may mediate adverse cardiac remodeling. In other pathophysiologic conditions, such as volume overload, diabetes mellitus, and obesity, the cell biological effectors mediating ECM remodeling are poorly understood and the molecular links between the primary insult and the changes in the matrix environment are unknown. This review article discusses the role of ECM macromolecules in heart failure, focusing on both structural ECM proteins (such as fibrillar and nonfibrillar collagens), and specialized injury-associated matrix macromolecules (such as fibronectin and matricellular proteins). Understanding the role of the ECM in heart failure may identify therapeutic targets to reduce geometric remodeling, to attenuate cardiomyocyte dysfunction, and even to promote myocardial regeneration.Keywords
This publication has 399 references indexed in Scilit:
- A Thrombospondin-Dependent Pathway for a Protective ER Stress ResponseCell, 2012
- Expression of collagen VI α5 and α6 chains in human muscle and in Duchenne muscular dystrophy-related muscle fibrosisMatrix Biology, 2012
- Differential effect of myocardial matrix and integrins on cardiac differentiation of human mesenchymal stem cellsDifferentiation, 2010
- Periostin Is a Novel Factor in Cardiac Remodeling After Experimental and Clinical Unloading of the Failing HeartThe Annals of Thoracic Surgery, 2009
- Matricellular proteins: an overviewJournal of Cell Communication and Signaling, 2009
- Thrombospondin-1 and CD47 regulate blood pressure and cardiac responses to vasoactive stressMatrix Biology, 2009
- Characterization of the inflammatory and fibrotic response in a mouse model of cardiac pressure overloadHistochemistry and Cell Biology, 2008
- Aging-Related Defects Are Associated With Adverse Cardiac Remodeling in a Mouse Model of Reperfused Myocardial InfarctionJournal of the American College of Cardiology, 2008
- Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissuesJournal of Cellular Biochemistry, 2007
- ColVa1 and ColXIa1 are required for myocardial morphogenesis and heart valve developmentDevelopmental Dynamics, 2006